UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists

Journal of medicinal chemistry, 2021-07, Vol.64 (13), p.9330-9353

2021

Volltextzugriff (PDF)

Acute drug intoxication in childhood: a 10-year retrospective observational single-centre study and case reports

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2023-09, Vol.167 (3), p.294-302

2023

Volltextzugriff (PDF)

Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions

Molecules (Basel, Switzerland), 2017-03, Vol.22 (4), p.509

2017

Volltextzugriff (PDF)

Interaction of rocuronium with human liver cytochromes P450

Journal of pharmacological sciences, 2015-02, Vol.127 (2), p.190-195

2015

Volltextzugriff (PDF)

In vitro and in silico studies of interaction of synthetic 2,6,9-trisubstituted purine kinase inhibitors BPA-302, BP-21 and BP-117 with liver drug-metabolizing cytochromes P450

Physiological research, 2020-12, Vol.69 (Suppl 4), p.S627-S636

2020

Volltextzugriff (PDF)

Lipophosphonoxins—A Novel Group of Broad Spectrum Antibacterial Compounds

Pharmaceutics, 2023-09, Vol.15 (10), p.2395

2023

Volltextzugriff (PDF)

The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro

Chemico-biological interactions, 2017-12, Vol.278, p.123-128

2017

Volltextzugriff (PDF)

Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450

Biochemical pharmacology, 2020-07, Vol.177, p.113912, Article 113912

2020

Volltextzugriff (PDF)

In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6

Bioorganic chemistry, 2024-03, Vol.144, p.107137-107137, Article 107137

2024

Volltextzugriff (PDF)

Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats

Xenobiotica, 2012-08, Vol.42 (8), p.731-736

2012

Volltextzugriff (PDF)

Evaluation of possible inhibition of human liver drug metabolizing cytochromes P450 by two new acetylcholinesterase oxime-type reactivators

Food and chemical toxicology, 2016-02, Vol.88, p.100-104

2016

Volltextzugriff (PDF)

1 – 11 von 11

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(11)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists

Acute drug intoxication in childhood: a 10-year retrospective observational single-centre study and case reports

Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions

Interaction of rocuronium with human liver cytochromes P450

In vitro and in silico studies of interaction of synthetic 2,6,9-trisubstituted purine kinase inhibitors BPA-302, BP-21 and BP-117 with liver drug-metabolizing cytochromes P450

Lipophosphonoxins—A Novel Group of Broad Spectrum Antibacterial Compounds

The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro

Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450

In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6

Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats

Evaluation of possible inhibition of human liver drug metabolizing cytochromes P450 by two new acetylcholinesterase oxime-type reactivators

Suchergebnisse filtern